J
067290
vs
K
KOSPI 200
Over the past 12 months, JW Shinyak Corp has underperformed KOSPI 200, delivering a return of +30% compared to the KOSPI 200's +123% growth.
Stocks Performance
067290 vs KOSPI 200
Performance Gap
067290 vs KOSPI 200
Performance By Year
067290 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JW Shinyak Corp
Glance View
JW SHINYAK Corp. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2003-02-11. The Company’s main products portfolio consists of antibiotics, anesthetics, respiratory remedies, urology remedies, cardiovascular remedies, allergy remedies, digestive remedies, anti-inflammatory drugs, antivirals as well as acne remedies, among others. In addition, it also involves in the provision of cosmetics, such as creams, cleansers, toners, essences, lotions and others.
